Immunocore Holdings plc (IMCR) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2022: $402.47M2023: $442.63M2024: $455.73M2025: $467.71M$467.71M
2022Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$467.71M+2.6%
2024$455.73M+3.0%
2023$442.63M+10.0%
2022$402.47M